Baxter International Inc's Customers have recorded an advance in their cost of revenue by
6.47 % in the 1 quarter 2025 year on year, sequentially costs of revenue were trimmed by
-5.27 %, for the same period Baxter International Inc revnue deteriorated by
-26.92 % year on year, sequentially revenue grew by 392.5 %.
• List of BAX Customers
| |
| 2021 |
|
 0.5 % |
of total Revenue |
| 2022 |
|
0.23 % |
of total Revenue |
| 2023 |
|
0.27 % |
of total Revenue |
| 2024 |
|
0.38 % |
of total Revenue |
| 2025 |
|
0.42 % |
of total Revenue |
| United States |
|
56.76 % |
of total Revenue |
| International |
|
43.24 % |
of total Revenue |
| Medical Products Therapies |
|
48.08 % |
of total Revenue |
| Healthcare Systems Technologies |
|
26.82 % |
of total Revenue |
| Pharmaceuticals |
|
22.13 % |
of total Revenue |
| United States Medical Products Therapies |
|
27.77 % |
of total Revenue |
| United States Healthcare Systems Technologies |
|
19.73 % |
of total Revenue |
| United States Pharmaceuticals |
|
7.43 % |
of total Revenue |
| International Medical Products Therapies |
|
20.3 % |
of total Revenue |
| International Healthcare Systems Technologies |
|
7.09 % |
of total Revenue |
| International Pharmaceuticals |
|
14.7 % |
of total Revenue |
| Infusion Therapies and Technologies Medical Products Therapies |
|
37.87 % |
of total Revenue |
| Infusion Therapies and Technologies United States Medical Products Therapies |
|
22.25 % |
of total Revenue |
| Infusion Therapies and Technologies International Medical Products Therapies |
|
15.62 % |
of total Revenue |
| Advanced Surgery Medical Products Therapies |
|
10.21 % |
of total Revenue |
| Advanced Surgery United States Medical Products Therapies |
|
5.52 % |
of total Revenue |
| Advanced Surgery International Medical Products Therapies |
|
4.69 % |
of total Revenue |
| Care and Connectivity Solutions Healthcare Systems Technologies |
|
16.27 % |
of total Revenue |
| Care and Connectivity Solutions United States Healthcare Systems Technologies |
|
12.04 % |
of total Revenue |
| Care and Connectivity Solutions International Healthcare Systems Technologies |
|
4.23 % |
of total Revenue |
| Front Line Care Healthcare Systems Technologies |
|
10.55 % |
of total Revenue |
| Front Line Care United States Healthcare Systems Technologies |
|
7.7 % |
of total Revenue |
| Front Line Care International Healthcare Systems Technologies |
|
2.86 % |
of total Revenue |
| Injectables and Anesthesia Pharmaceuticals |
|
12.76 % |
of total Revenue |
| Injectables and Anesthesia United States Pharmaceuticals |
|
7.43 % |
of total Revenue |
| Injectables and Anesthesia International Pharmaceuticals |
|
5.33 % |
of total Revenue |
| Drug Compounding Pharmaceuticals |
|
9.37 % |
of total Revenue |
| Drug Compounding International Pharmaceuticals |
|
9.37 % |
of total Revenue |
| Other |
|
2.97 % |
of total Revenue |
| Other United States |
|
1.83 % |
of total Revenue |
| Other International |
|
1.14 % |
of total Revenue |
| Emerging Markets |
|
11.31 % |
of total Revenue |
| Rest of world |
|
31.92 % |
of total Revenue |
0.09 %